Children's National Medical Center — Washington D.C., District of Columbia

Public research footprint of Children's National Medical Center, compiled from the ClinicalTrials.gov public registry.

904

Registered studies

209

Active

107

Recruiting now

585

Completed

Stopped or withdrawn

Most-studied conditions

Acute Lymphoblastic Leukemia · Botryoid-Type Embryonal Rhabdomyosarcoma · Spindle Cell Rhabdomyosarcoma · Ann Arbor Stage III Lymphocyte-Depleted Classic Hodgkin Lymphoma

Recently updated registry entries

NCT05621291 — A Multicenter Study to Evaluate Next-Generation Sequencing (NGS) Testing and Monitoring… (Recruiting)
NCT04320888 — Selpercatinib for the Treatment of Advanced Solid Tumors, Lymphomas, or Histiocytic… (Active Not Recruiting)
NCT03907488 — Immunotherapy (Nivolumab or Brentuximab Vedotin) Plus Combination Chemotherapy in… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Children's National Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 03, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.